CCN3 Impairs Osteoblast and Stimulates Osteoclast Differentiation to Favor Breast Cancer Metastasis to Bone
- 1 May 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (5), 2377-2388
- https://doi.org/10.1016/j.ajpath.2011.01.033
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-β/MAPK Signaling PathwaysPublished by Elsevier BV ,2009
- Matricellular Protein CCN3 (NOV) Regulates Actin Cytoskeleton ReorganizationJournal of Biological Chemistry, 2009
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- CCN3 and bone marrow cellsJournal of Cell Communication and Signaling, 2009
- CCN3: a key growth regulator in Chronic Myeloid LeukaemiaJournal of Cell Communication and Signaling, 2009
- Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancerJournal of Molecular Endocrinology, 2008
- Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and InvasionMolecular and Cellular Biology, 2008
- Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) geneBMC Developmental Biology, 2008
- CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in MelanomaCancer Research, 2008
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001